Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KYMR Kymera Therapeutics, Inc.

交易中 12-24 12:17:26 EST

40.64

-0.15

-0.37%

最高41.71	最低40.14	成交量5.13万
今开40.45	昨收40.79	日振幅3.84%
总市值26.32亿	流通市值17.63亿	总股本6,477万
成交额208.84万	换手率0.12%	流通股本4,337万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":40.64,"timestamp":1735060584417,"preClose":40.79,"halted":0,"volume":51344,"delay":0,"floatShares":43374087,"shares":64765274,"eps":-2.405245,"marketStatus":"交易中","marketStatusCode":2,"change":-0.15,"latestTime":"12-24 12:17:26 EST","open":40.45,"high":41.705,"low":40.14,"amount":2088415.40296,"amplitude":0.038367,"askPrice":40.68,"askSize":40,"bidPrice":40.58,"bidSize":118,"shortable":3,"etf":0,"ttmEps":-2.405245,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1735063200000},"adr":0,"listingDate":1597982400000,"adjPreClose":40.79,"preHourTrading":{"tag":"盘前","latestPrice":40.79,"preClose":40.79,"latestTime":"08:41 EST","volume":5,"amount":198.98,"timestamp":1735047683915},"postHourTrading":{"tag":"盘后","latestPrice":40.79,"preClose":40.79,"latestTime":"16:08 EST","volume":10006,"amount":408143.95,"timestamp":1734988101529},"volumeRatio":0.178675,"impliedVol":0.6686,"impliedVolPercentile":0.373},"requestUrl":"/m/hq/s/KYMR","defaultTab":"news","newsList":[{"id":"2492174070","title":"Kymera Therapeutics, Inc.盘中异动 早盘快速跳水5.04%报37.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492174070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492174070?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:01","pubTimestamp":1734620476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时01分，Kymera Therapeutics, Inc.股票出现波动，股价快速下跌5.04%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.44%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219230116a1fb6559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219230116a1fb6559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KYMR","BK4139"],"gpt_icon":0},{"id":"2492156805","title":"Kymera Therapeutics, Inc.盘中异动 下午盘急速下跌5.11%报40.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492156805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492156805?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:14","pubTimestamp":1734552873,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时14分，Kymera Therapeutics, Inc.股票出现异动，股价急速下跌5.11%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.05%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219041434a1f94fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219041434a1f94fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2491332518","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491332518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491332518?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:22","pubTimestamp":1734024122,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时22分，Kymera Therapeutics, Inc.股票出现异动，股价大幅下跌5.19%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213012202984b9d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213012202984b9d2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2490748347","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大跌5.12%报44.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490748347?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:44","pubTimestamp":1733759056,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时44分，Kymera Therapeutics, Inc.股票出现波动，股价快速跳水5.12%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234416984ac858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234416984ac858&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2489757231","title":"Kymera Therapeutics, Inc.盘中异动 早盘大幅上涨5.15%报46.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489757231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489757231?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:01","pubTimestamp":1733497305,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时01分，Kymera Therapeutics, Inc.股票出现波动，股价快速上涨5.15%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230145971c2658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230145971c2658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2489418817","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489418817","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489418817?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:40","pubTimestamp":1733431214,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时40分，Kymera Therapeutics, Inc.股票出现异动，股价急速跳水5.11%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206044014971bf02a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206044014971bf02a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KYMR"],"gpt_icon":0},{"id":"1118082847","title":"富国银行：上调Kymera评级，预计在牛市中有大涨75%的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1118082847","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118082847?lang=zh_cn&edition=full","pubTime":"2024-12-03 10:27","pubTimestamp":1733192859,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics 股票评级被上调，未来上涨潜力较大富国银行分析师 Derek Archila 最近将 Kymera Therapeutics的股票评级从“持股”上调至“增持”，并将目标股价上调至57美元，较上周五的收盘价上涨了 21% 以上。Dupixent 是一种注射药物，在过去 12 个月内为市场带来了约 136 亿美元 的销售额。目前，华尔街对 Kymera 的看法总体乐观。受评级上调的影响，Kymera的股价在周一的交易中上涨了超过2%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"富国银行：上调Kymera评级，预计在牛市中有大涨75%的潜力","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR"],"gpt_icon":1},{"id":"2486034625","title":"Kymera Therapeutics, Inc.盘中异动 股价大涨5.02%报47.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486034625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486034625?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:45","pubTimestamp":1732549529,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时45分，Kymera Therapeutics, Inc.股票出现波动，股价急速拉升5.02%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.03%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234530971a86b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234530971a86b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","BK4139","LENZ"],"gpt_icon":0},{"id":"2485299897","title":"Kymera Therapeutics, Inc.盘中异动 大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485299897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485299897?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:53","pubTimestamp":1732294394,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时53分，Kymera Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123005314a24e5c7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123005314a24e5c7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KYMR"],"gpt_icon":0},{"id":"2484960389","title":"美国研究综述-Equifax、Microstrategy、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484960389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484960389?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000212,"startTime":"0","endTime":"0","summary":"美国研究综述-Equifax、Microstrategy、Netflix路透11月19日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Equifax、Microstrategy 和 Netflix。要闻  * 凯斯百货公司CASY.O：杰富瑞将目标价从 450 美元上调至 470 美元 * Equifax Inc EFX.N：摩根大通将目标价从304美元下调至283美元 * Microstrategy Inc MSTR.O：Benchmark将目标价从300美元上调至450美元 * Netflix Inc NFLX.O：杰富瑞将目标价从800美元上调至1000美元 * Palo Alto Networks Inc PANW.O：杰富瑞将目标价从400美元上调至450美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEOH","KHC","CPRX","LU1429558221.USD","IDYA","LU1571399168.USD","LU0106261372.USD","MSTR","LU2237957902.USD","CGEM","EFX","LU0109394709.USD","CASY","MRNA","MOS","FNV","LU2249611893.SGD","BK4107","PTCT","EHAB","LU2326559502.SGD","CCCC","FENC","RDDT","PANW","CHPT","VRT","FTNT","LOVE","CPRT","DCOM","ARVN","NFLX","WSM","RC","ACRS","IE00BQXX3C00.GBP","RGNX","BK4588","LU1046421795.USD","PLUG","BK4077","KMPR","LU1670710661.SGD","BK4113","BECN","KYMR","BK4585","QS"],"gpt_icon":1},{"id":"2483332337","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332337?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:54","pubTimestamp":1731617693,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时54分，Kymera Therapeutics, Inc.股票出现波动，股价急速下跌5.22%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.03%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504545398e42bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504545398e42bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2483059976","title":"Kymera Therapeutics, Inc.盘中异动 下午盘大幅跳水5.25%报49.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483059976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483059976?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:26","pubTimestamp":1731443190,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时26分，Kymera Therapeutics, Inc.股票出现波动，股价快速跳水5.25%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113042630abbaedde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113042630abbaedde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2482489947","title":"Kymera Therapeutics, Inc.2024财年第三财季实现净利润-62.49百万美元，同比减少18.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482489947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482489947?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081630,"startTime":"0","endTime":"0","summary":"11月9日，Kymera Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-62.49百万美元，同比减少18.20%；其中营业收入为3.74百万美元，同比减少20.93%，每股基本收益为-0.82美元。从资产负债表来看，Kymera Therapeutics, Inc.总负债1.42亿美元，其中短期债务12.85百万美元，资产负债比为7.29，流动比率为0.09。机构评级：截至2024年11月9日，当前有16家机构对Kymera Therapeutics, Inc.目标价做出预测，其中目标均价为57.31美元，其中最低目标价为38.00美元，最高目标价为90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000216abae6f51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000216abae6f51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ"],"gpt_icon":0},{"id":"2481556985","title":"Kymera Therapeutics, Inc.盘中异动 大幅拉升6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481556985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481556985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903543,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Kymera Therapeutics, Inc.股票出现波动，股价急速拉升6.33%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622322698e40dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622322698e40dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2479080060","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌7.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080060?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:32","pubTimestamp":1730381562,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时32分，Kymera Therapeutics, Inc.股票出现波动，股价快速下挫7.64%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.85%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121324295bd9c2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121324295bd9c2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2476925484","title":"Kymera Therapeutics, Inc.盘中异动 下午盘急速下挫5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476925484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476925484?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:30","pubTimestamp":1729189804,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时30分，Kymera Therapeutics, Inc.股票出现异动，股价大幅跳水5.22%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018023005a1e171a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018023005a1e171a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","BK4139","LENZ"],"gpt_icon":0},{"id":"2475491685","title":"Kymera Therapeutics, Inc.盘中异动 大幅拉升5.33%报47.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475491685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475491685?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:18","pubTimestamp":1729088321,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时18分，Kymera Therapeutics, Inc.股票出现波动，股价快速拉升5.33%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622184198e3ccb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622184198e3ccb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","BK4139","LENZ"],"gpt_icon":0},{"id":"2470876804","title":"Kymera Therapeutics, Inc.盘中异动 急速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470876804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470876804?lang=zh_cn&edition=full","pubTime":"2024-09-27 01:39","pubTimestamp":1727372375,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日01时39分，Kymera Therapeutics, Inc.股票出现异动，股价大幅下挫5.16%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092701393598e39280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092701393598e39280&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2470449115","title":"Kymera Therapeutics, Inc.盘中异动 临近收盘股价大涨5.24%报52.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470449115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470449115?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:41","pubTimestamp":1727206882,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时41分，Kymera Therapeutics, Inc.股票出现异动，股价大幅上涨5.24%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092503412298e38b79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092503412298e38b79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2470008112","title":"美国研究综述-Cintas、纳斯达克、Talen Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2470008112","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470008112?lang=zh_cn&edition=full","pubTime":"2024-09-24 20:39","pubTimestamp":1727181557,"startTime":"0","endTime":"0","summary":"美国研究综述-Cintas、纳斯达克、Talen Energy路透9月26日 - 华尔街证券分析师周四修改了对几家美国上市公司的评级和目标价，其中包括 Cintas、Nasdaq 和 Talen Energy。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240924:nL4T3L615A:11","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","DKNG","BANR","WABC","FLUT","NQmain","LEGN","CHK","TLNE","GPN","LSEG.UK","CME","TW","IE00BJJMRX11.SGD","PNTG","MNQmain","LU1093756325.SGD","WOR","VRDN","01548","CTAS","EMR","LPG","KYMR","FHB","HTLF","ICE","CPF","PROV","SQQQ","CBOE","FINW","NDAQ","QLD","TQQQ","ECL","KDP","PSQ","NBHC","BMY","EHC","FNWB",".IXIC","TLN","ARTL"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.kymeratx.com","stockEarnings":[{"period":"1week","weight":-0.0527},{"period":"1month","weight":-0.0932},{"period":"3month","weight":-0.2216},{"period":"6month","weight":0.3647},{"period":"1year","weight":0.5872},{"period":"ytd","weight":0.6021}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kymera Therapeutics, Inc.，一家根据特拉华州法律于2017年5月25日成立的有限责任公司。该公司是一家生物制药公司，致力于发现和开发新颖的小分子疗法，该疗法可通过利用药物选择性地降解致病蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.111455},{"month":2,"riseRate":0.25,"avgChangeRate":-0.034182},{"month":3,"riseRate":0.25,"avgChangeRate":-0.060002},{"month":4,"riseRate":0.5,"avgChangeRate":-0.04657},{"month":5,"riseRate":0.25,"avgChangeRate":-0.150138},{"month":6,"riseRate":0.5,"avgChangeRate":0.024718},{"month":7,"riseRate":0.75,"avgChangeRate":0.214781},{"month":8,"riseRate":0.75,"avgChangeRate":0.05865},{"month":9,"riseRate":0.2,"avgChangeRate":-0.112915},{"month":10,"riseRate":0.6,"avgChangeRate":0.065},{"month":11,"riseRate":0.6,"avgChangeRate":0.197535},{"month":12,"riseRate":0.6,"avgChangeRate":0.086243}],"exchange":"NASDAQ","name":"Kymera Therapeutics, Inc.","nameEN":"Kymera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kymera Therapeutics, Inc.(KYMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kymera Therapeutics, Inc.,KYMR,Kymera Therapeutics, Inc.股票,Kymera Therapeutics, Inc.股票老虎,Kymera Therapeutics, Inc.股票老虎国际,Kymera Therapeutics, Inc.行情,Kymera Therapeutics, Inc.股票行情,Kymera Therapeutics, Inc.股价,Kymera Therapeutics, Inc.股市,Kymera Therapeutics, Inc.股票价格,Kymera Therapeutics, Inc.股票交易,Kymera Therapeutics, Inc.股票购买,Kymera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kymera Therapeutics, Inc.(KYMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}